|
(V969) |
Subclinical Brain Infarctions but not Cerebrovascular Microembolic Events after TAVI negatively impact Cognitive Function and Cerebral Morphology in Long-Term Follow-up |
| |
|
A. Ghanem, J. Dörner, L. Schulze-Hagen, A. Müller, M. Wilsing, J.-M. Sinning, C. Frerker, K.-H. Kuck, N. Werner, E. Grube, G. Nickenig (Hamburg, Bonn) |
|
|
Diskussion |
|
(V970) |
The incidence of pseudoaneurysm formation after transcatheter aortic valve implantation (TAVI) |
| |
|
S. Fateh-Moghadam, R. Jorbenadze, A. Kilias, M. Droppa, P. Htun, M. Gawaz, W. Bocksch (Tübingen) |
|
|
Diskussion |
|
(V971) |
Procedural and clinical predictors for 30 day stroke after transfemoral TAVI |
| |
|
S. Fateh-Moghadam, A. Prinz, S. Voesch, T. Geisler, M. Gawaz, W. Bocksch (Tübingen) |
|
|
Diskussion |
|
(V972) |
Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve implantation |
| |
|
M. Abdel-Wahab, J. Jose, D. Sulimov, M. El-Mawardy, T. Sato, A. Allali, B. Becker, M. Landt, B. Schwarz, G. Richardt (Bad Segeberg) |
|
|
Diskussion |
|
(V973) |
Comparison of suture mediated femoral access site closure in transfemoral aortic valve implantation with the Prostar compared to the Proglide system |
| |
|
J. Seeger, B. Gonska, C. Rodewald, W. Rottbauer, J. Wöhrle (Ulm) |
|
|
Diskussion |
|
(V974) |
Impact of Closure Devices in TAVI Procedures on Vascular Complications And Mortality |
| |
|
Z. Dimitriadis, W. Scholtz, J. Börgermann, M. Wiemer, C. Piper, M. Vlachojannis, S. Ensminger, T. Bitter, L. Faber, D. Horstkotte, S. Scholtz (Bad Oeynhausen) |
|
|
Diskussion |